Tag: biosimilar

May 16, 2022
IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.

READ MORE
January 17, 2022
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

READ MORE
January 9, 2020
Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

READ MORE
December 9, 2019
New Drug Developments Impacting Comp

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

READ MORE
lockenvelopephone-handsetmenucross-circle